Highlights from the 2025 Muscular Dystrophy Association (MDA) Conference include clinical updates, expert insights, and ...

Chennai: The Institute of Child Health (ICH) has seen a sharp rise in cases of genetic disorders since its launch in 2022, ...

Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

Italfarmaco & JCR Pharma enter commercialisation agreement for givinostat to treat Duchenne muscular dystrophy in Japan: Milan, Italy Monday, December 29, 2025, 14:00 Hrs [IST] It ...

Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for ...

Fakeeh University Hospital is emerging as a global destination for advanced gene therapy, delivering highly specialized ...

California-based Foresite Capital Management VI fully exited Edgewise Therapeutics (NASDAQ:EWTX) in the quarter ended ...

Fakeeh University Hospital is emerging as a global destination for advanced gene therapy, delivering highly specialized ...

The sudden ascent of the AI therapist seems startlingly futuristic, as if it should be unfolding in some later time when the ...

US gene therapy company Regenxbio’s clemidsogene lanparvovec has a plausible pathway to US Food and Drug Administration (FDA) ...

The film “Lilly,” released in spring of 2025, tells the story of Lilly Ledbetter, the Jacksonville, Ala., native who famously ...

By Jeanette Jackson McDaniel What a joy and blessing it is to write for The Star-Herald. I am always anxious to read what other writers have to share. We truly have a good, interesting newspaper. I ...